Fifth Third Bancorp Purchases 256,912 Shares of CVS Health Corporation $CVS

Fifth Third Bancorp lifted its position in shares of CVS Health Corporation (NYSE:CVS) by 175.6% during the 1st quarter, HoldingsChannel.com reports. The firm owned 403,201 shares of the pharmacy operator’s stock after buying an additional 256,912 shares during the quarter. Fifth Third Bancorp’s holdings in CVS Health were worth $28,958,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Hamlin Capital Management LLC bought a new position in CVS Health in the 4th quarter worth approximately $160,844,000. Capitolis Liquid Global Markets LLC acquired a new stake in CVS Health in the 3rd quarter valued at approximately $11,308,000. National Bank of Canada FI raised its stake in CVS Health by 50.3% during the 3rd quarter. National Bank of Canada FI now owns 1,770,840 shares of the pharmacy operator’s stock valued at $133,495,000 after acquiring an additional 593,015 shares in the last quarter. State Street Corp boosted its position in CVS Health by 2.1% during the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares during the period. Finally, Fort Washington Investment Advisors Inc. OH boosted its position in CVS Health by 2.9% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 725,189 shares of the pharmacy operator’s stock worth $57,551,000 after acquiring an additional 20,217 shares during the period. Institutional investors own 80.66% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Tilak Mandadi sold 69,551 shares of the company’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the sale, the executive vice president directly owned 10,133 shares in the company, valued at approximately $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Larry Robbins sold 1,983,538 shares of the company’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total value of $187,345,164.10. Following the sale, the director owned 6,213,261 shares of the company’s stock, valued at approximately $586,842,501.45. This trade represents a 24.20% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,441,551 shares of company stock worth $323,703,977 in the last 90 days. 0.85% of the stock is owned by insiders.

CVS Health Stock Up 1.8%

CVS stock opened at $105.97 on Tuesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66. The firm has a market capitalization of $135.21 billion, a P/E ratio of 46.68, a P/E/G ratio of 1.02 and a beta of 0.61. CVS Health Corporation has a 52-week low of $58.50 and a 52-week high of $106.40. The company’s 50 day simple moving average is $97.36 and its 200-day simple moving average is $84.41.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, topping analysts’ consensus estimates of $2.21 by $0.36. The firm had revenue of $100.43 billion during the quarter, compared to analyst estimates of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period last year, the company posted $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. As a group, equities research analysts anticipate that CVS Health Corporation will post 7.44 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, July 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.5%. CVS Health’s dividend payout ratio is 117.18%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CVS. Royal Bank Of Canada increased their target price on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research report on Thursday. Mizuho boosted their price target on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Bank of America increased their price objective on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Finally, Sanford C. Bernstein raised their price objective on shares of CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a research note on Tuesday, May 12th. Twenty-one investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $103.64.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.